Cargando…
A pilot clinical trial to determine the safety and efficacy of aerosolized hyaluronan as a treatment for COPD
A novel therapy for COPD involving the use of aerosolized hyaluronan (HA) was tested on a small cohort of COPD patients to determine both its safety and efficacy in reducing levels of desmosine and isodesmosine (DID), biomarkers for elastin degradation. In a 2-week, randomized, double-blind trial, 8...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609793/ https://www.ncbi.nlm.nih.gov/pubmed/29075107 http://dx.doi.org/10.2147/COPD.S142156 |